PKIのチャート
PKIの企業情報
| symbol | PKI |
|---|---|
| 会社名 | PerkinElmer Inc. （PKI パ―キンエルマ―） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 パーキン・エルマー（PerkinElmer Inc.）は診断、研究、環境、工業及び実験サービス市場向けに製品、サービス及びソリューションを提供する会社である。同社は2つの事業セグメントを運営する。ディスカバリー＆分析ソリューション部門は、環境、食品、工業、ライフサイエンスの研究及び研究サービス市場にサービスを提供する。同社は化学、エレクトロニクス、エネルギー、潤滑油、石油化学および高分子工業を含む産業市場向けの分析機器を提供する。同社の製品には、AAnalyst、Altus、Aquamatic、Avio、Axion、Clarus、DairyGuard、AlphaLISA、AlphaPlex、AlphaScreen、Alpha SureFire、Cell carrier、cell :: explorerなどがある。診断部門は、リプロダクティブヘルス、新興市場診断、応用ゲノミクスに重点を置く。同社の製品には、AutoDELFIA、BACS-on-Beads、Bioo Scientific、BoBs、Datalytix、Dexela、Dexela CMOS FPD、Evolution、ViaCord、及びZephyrが含まれる。 パ―キンエルマ―は米国の分析機器メ―カ―。一般産業、検査市場向けに各種分析機器、消耗品、サ―ビスを提供。疾病の早期発見と治療法開発用に分析装置、測定装置、および関連ソフトウエア開発を提供するほか、食品や消費者製品の安全と環境対策向けに分析技術、システムを提供。主要製品は｢Delfia｣、｢Tri-Carb｣、｢Flexar｣など。 PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index. |
| 本社所在地 | 940 Winter Street Waltham MA 02451 USA |
| 代表者氏名 | Robert F. Friel |
| 代表者役職名 | Chairman of the Board Chief Executive Officer |
| 電話番号 | +1 781-663-5776 |
| 設立年月日 | 17472 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 12500人 |
| url | www.perkinelmer.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | EBITDA（百万ドル） 515.61600 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | 時価総額（百万ドル） 10676.97000 |
| 売上高 | 売上高（百万ドル） 2777.99600 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 12405.33900 |
| 当期純利益 | 当期純利益（百万ドル） 235.45000 |
| 決算概要 | 決算概要 BRIEF: For the fiscal year ended 30 December 2018 PerkinElmer Inc. revenues increased 23% to $2.78B. Net income before extraordinary items decreased 11% to $235.5M. Revenues reflect Diagnostics segment increase of 60% to $1.08B Discovery_Analytical Solutions segment increase of 7% to $1.69B China segment increase of 49% to $559.9M Other Foreign segment increase of 29% to $731.7M United States segment increase of 8% to $906.4M. |
PKIのテクニカル分析
PKIのニュース
Parkland Corporation Announces the Results of the 2023 Annual and Special Meeting of Shareholders 2023/05/05 02:01:00 Kwhen Finance
PerkinElmer: Remains A Buy For Long-Term Positioning (NYSE:PKI) 2023/04/26 10:24:40 Seeking Alpha
PerkinElmer remains a good steward of capital and a long-term value creator. Click here to see why PKI stock is a Buy.
Short-read Sequencing Market is Poised to Surge at a CAGR of 18.46% to Reach a Humungous Revenue During Forecast Period of 2023 to 2033 | Latest Data by Future Market Insights, Inc. 2023/04/18 03:30:00 Accesswire
NEWARK, DE / ACCESSWIRE / April 17, 2023 / The Short-Read Sequencing Market size is projected to be valued at US$ 6,322.03 million in 2023 and is expected to rise to US$ 34,401.22 million by 2033. The sales of short-read sequencing are projected to expand at a significant CAGR of 18.46% during the forecast period. The global short-read sequencing market is a notably expanding industry that includes technologies and services that enable high-throughput sequencing of DNA or RNA fragments. Short-read sequencing technologies can produce millions or billions of short DNA or RNA reads, with typical lengths ranging from 50 to 300 base pairs. Drivers and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16920 Several key factors are driving the short-read sequencing market, including rising demand for genomic analysis in clinical diagnostics, personalized medicine, drug discovery, and agriculture.
Biomarkers Market Report 2023: Increase in Funds and Grants for Biomarker Research Bolsters Sector 2023/03/15 23:15:00 Kwhen Finance
PerkinElmer Inc. (PKI) Presents at Cowen 43rd Annual Health Care Conference (Transcript) 2023/03/09 16:18:02 Seeking Alpha
PerkinElmer Inc. (NYSE:NYSE:PKI) Cowen 43rd Annual Health Care Conference March 6, 2023 9:10 AM ETCompany ParticipantsMaxwell Krakowiak - CFOConference Call ParticipantsMax Masucci - Cowen…
High-Performance Liquid Chromatography Global Market Report 2022: Ukraine-Russia War Impact 2022/12/20 12:37:00 GlobeNewswire
Major players in the high-performance liquid chromatography market are Waters Corporation, Agilent Technologies Inc, Shimadzu Corporation, Thermo Fisher Scientific Inc, PerkinElmer Inc, General Electric Company, Bio-Rad Laboratories Inc, Merck Millipore, Hitachi High-Technologies Corporation, Showa Denko K K, Gilson Inc, Phenomenex, Jasco Inc, Hamilton Company, Tosoh Corporation, YMC CO LTD, Danaher Corporation, Restek, SIELC Technologies, Trajan Scientific Australia Pty Ltd, Sartorius AG and Mitsubishi Chemical Corporation. Major players in the high-performance liquid chromatography market are Waters Corporation, Agilent Technologies Inc, Shimadzu Corporation, Thermo Fisher Scientific Inc, PerkinElmer Inc, General Electric Company, Bio-Rad Laboratories Inc, Merck Millipore, Hitachi High-Technologies Corporation, Showa Denko K K, Gilson Inc, Phenomenex, Jasco Inc, Hamilton Company, Tosoh Corporation, YMC CO LTD, Danaher Corporation, Restek, SIELC Technologies, Trajan Scientific Australia Pty Ltd, Sartorius AG and Mitsubishi Chemical Corporation.
KeyBanc Upgrades PerkinElmer to Overweight 2022/12/19 08:43:10 Investing.com
https://www.investing.com/news/pro/keybanc-upgrades-perkinelmer-to-overweight-432SI-2966925
Global Microarray Market Report 2022-2028: Rising Use of Microarrays to Diagnose Infectious Diseases Fuels Growth - ResearchAndMarkets.com 2022/12/16 11:01:00 Kwhen Finance
Global Pre-clinical Imaging Market Report to 2029 - Featuring Bruker, Siemens, General Electric and TriFoil Imaging Among Others - ResearchAndMarkets.com 2022/12/14 10:35:00 Kwhen Finance
PerkinElmer upgraded at Cowen on profitability potential 2022/12/06 21:08:25 Investing.com
https://www.investing.com/news/stock-market-news/perkinelmer-upgraded-at-cowen-on-profitability-potential-432SI-2958551
Cowen Upgrades PerkinElmer to Outperform 2022/12/06 08:25:02 Investing.com
https://www.investing.com/news/pro/cowen-upgrades-perkinelmer-to-outperform-432SI-2957939